Quick Facts
| Legal Status | Medical Since | Adult Use | Access Type | Est. Monthly Cost | Insurance |
|---|---|---|---|---|---|
| Medical Legal — Established Programme | 1992 (pilot) / 2011 (programme) / 2023 (adult-use legalisation passed) | Yes (legalised 2023) | Specialist prescription via IMCA (IMC-A) licensed dispensaries | ₪400–₪1,200/month | Partial (Kupat Holim) |
Legal Timeline
| Year | Development |
|---|---|
| 1992 | First medical cannabis authorisation issued — beginning of informal programme |
| 2011 | Israel Medical Cannabis Agency (IMCA) formalises the medical programme |
| 2016 | Over 20,000 patients enrolled; programme one of world's largest |
| 2021 | Israel becomes a leading global cannabis research hub |
| 2022 | Parliament votes to legalise recreational cannabis |
| 2023 | Adult-use legalisation formally enacted — landmark moment for global policy |
How to Access Medical Cannabis in Israel
- Consult your doctor or specialist; most conditions now accessible via general physician
- Doctor submits application to IMCA for cannabis licence on your behalf
- IMCA issues a medical cannabis licence (normally within 1–2 weeks)
- Visit an IMCA-licensed dispensary to select products — large variety available
- Monthly purchase limits apply based on your licence category
- Annual renewal required; most renewals are straightforward
Qualifying Conditions
- Chronic pain (largest group)
- Cancer-related pain and nausea
- PTSD
- MS spasticity
- Parkinson's disease
- Crohn's disease
- Epilepsy
- Anxiety disorders
- Palliative care
- HIV/AIDS
Licensed Providers & Clinics
| Provider | Website | Notes |
|---|---|---|
| IMCA | health.gov.il | Israeli Medical Cannabis Authority — licence issuer |
| Tikun Olam | tikunolam.com | Pioneering Israeli licensed producer and research company |
| Cannabliss | Major Israeli dispensary network | |
| BOL Pharma | Leading Israeli medical cannabis producer and exporter |
Cost Breakdown
| Item | Estimated Cost (ILS (₪)) | Insurance Coverage |
|---|---|---|
| Flower (10g) | ₪120–₪200 (~€30–€50) | Kupat Holim partial coverage possible |
| Oil (20ml) | ₪100–₪200 | Kupat Holim partial possible |
| Monthly total estimate | ₪400–₪1,200 | Varies by Kupat Holim fund |
Frequently Asked Questions
Is medical cannabis legal in Israel?+
Yes — Israel has one of the world's most established medical cannabis programmes, running formally since 2011. In 2023, Israel became one of the first countries to legalise adult recreational use while maintaining its highly developed medical programme.
How do I get a medical cannabis licence in Israel?+
Your doctor submits an application to IMCA on your behalf. Once approved, you can purchase from any licensed dispensary. The process typically takes 1–2 weeks. Israel's programme has been significantly liberalised — access is now far easier than in the programme's early years.
Is Israeli cannabis medical research significant?+
Israel is a global leader in cannabis research. Hebrew University's Raphael Mechoulam discovered THC and CBD, and Israel hosts numerous clinical trials and pharmaceutical cannabis companies. Israeli research has shaped global understanding of the endocannabinoid system.
Does Israeli health insurance cover cannabis?+
The four Kupat Holim (health fund) organisations have varying coverage. Some cover specific products for specific conditions. Coverage has expanded gradually. Patients should check with their specific health fund (Clalit, Maccabi, Meuhedet, Leumit) for current policy.
What is the Israeli cannabis market like?+
Israel has a highly developed cannabis market with dozens of licensed producers, multiple dispensary chains, and a wide range of products. The 2023 adult-use legalisation has expanded access significantly. Israeli producers also export cannabis to Germany, the UK, and Australia.
Can tourists access medical or recreational cannabis in Israel?+
With adult-use legalisation in 2023, the framework for tourist access is developing. Medical cannabis still requires an IMCA licence. Check current regulations before travelling as the adult-use implementation is evolving.